NCT00001750View on ClinicalTrials.gov

Comparing Treatments for Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 1998

Study Completion Date

August 31, 2002

Conditions
Multiple Myeloma
Interventions
DRUG

Stemgen

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001750 - Comparing Treatments for Multiple Myeloma | Biotech Hunter | Biotech Hunter